Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer

BACKGROUND: EGFR-positive Non-small Cell Lung Cancer (NSCLC) is a dynamic entity and tumor progression and resistance to tyrosine kinase inhibitors (TKIs) arise from the accumulation, over time and across different disease sites, of subclonal genetic mutations. For instance, the occurrence of EGFR T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Cucchiara, Federico, Del Re, Marzia, Valleggi, Simona, Romei, Chiara, Petrini, Iacopo, Lucchesi, Maurizio, Crucitta, Stefania, Rofi, Eleonora, De Liperi, Annalisa, Chella, Antonio, Russo, Antonio, Danesi, Romano
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819134/
https://ncbi.nlm.nih.gov/pubmed/33489892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.593831
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares